Patients with extensive-stage small cell lung cancer (ES-SCLC ... with chemotherapy and continued as adjuvant treatment after surgery. School nurses play an overworked and understaffed role ...

Infusion reactions that can sometimes be severe or life-threatening. Signs and symptoms of infusion reactions may include: ...

John Ryan, a U.S. Navy veteran, beat cancer through nearly a decade of experimental immunotherapy treatment. The vet shared ...

Bristol Myers Squibb has bolstered its case for Opdivo to be used as a pre-operative treatment for non-small cell lung cancer ...

In localized non-small cell lung cancer (NSCLC), a tumor's ability to use carbon from glucose to feed the tricarboxylic acid ...

When added to chemotherapy, researchers found no significant difference in overall or progression-free survival between PD-1 ...

For patients with stage IA non-small cell lung cancer (NSCLC), lung resections ... data from 32,340 patients undergoing lung resection surgery for stage IA NSCLC from 346 U.S. institutions ...

How Do Opdivo and Opdivo Qvantig Work for Lung Cancer? Some cancer cells have what are called checkpoint proteins on their cell surface ... that can be removed by surgery (resectable).

Researchers from the Francis Crick Institute have found that some particularly aggressive lung cancer cells can develop their own electric network, like that seen in the body's nervous system.

Bristol Myers Squibb & Co (NYSE:BMY) announced the final analysis of overall survival (OS) from the Phase 3 CheckMate -816 ...

With 44,000 new diagnoses each year, non-small cell lung cancer is the second most frequent neoplasm in Italy after breast ...